Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial.
Obstetrics and gynecology(2023)
摘要
ClinicalTrials.gov , NCT04003389.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Obstetrics and gynecology(2023)